Loading clinical trials...
Loading clinical trials...
This study is prospective single arm extension study of protocol AAG-G-H-1220. It is open only to participants of AAG-G-H-1220 randomized to the Microfracture treatment group.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Aesculap Biologics, LLC
NCT06915233 · Chondral Defect, Articular Cartilage Defect
NCT03588975 · Chondral Defect, Osteochondritis Dissecans (OCD), and more
NCT04840147 · Chondral Defect, Articular Cartilage Defect, and more
NCT05651997 · Articular Cartilage Defect, Chondral Defect, and more
NCT01656902 · Traumatic Articular Cartilage Defects in the Knee Joint
Rush University Medical Center
Chicago, Illinois
Ohio State University Wexner Medical Center
Columbus, Ohio
Alpine Orthopaedics
North Logan, Utah
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions